Phase II Study to Evaluate the Efficacy and Safety of TLC388 for Differentiated Neuroendocrine Carcinomas Patients
Clinical trial NCT02457273 · COMPLETED
Trial details
- NCT number
- NCT02457273
- Sponsor
- National Health Research Institutes, Taiwan
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-04
- Primary completion
- 2018-04-18
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.